Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss Drugs

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 19 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 42%
  • Publisher: 59%

Ozempic Nyheter

Wegovy,Mounjaro,Novo Nordisk

Robert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.

The stellar success of blockbuster drugs like Ozempic, Wegovy, Mounjaro and Zepbound has companies eager to break into the lucrative weight loss drug market — here are the hopeful rivals preparing to challenge Eli Lilly and Novo Nordisk for dominance in the obesity drug gold rush.

There is no guarantee promising results on efficacy, safety and tolerability from earlier trials will be replicated in larger late-stage trials. Even companies with candidates already in the later stages of testing are still going to require several years to gather and process the data and, should things pan out, time to work with regulators to secure approval.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 318. in SE

Sverige Senaste nytt, Sverige Rubriker